95 related articles for article (PubMed ID: 6789299)
1. [A circulating inhibitor specific to factor V. Clinical, biological and therapeutic study (author's transl)].
Lerolle D; Dreyer-Dufer C; Allain JP
Nouv Presse Med; 1981 Apr; 10(18):1483-7. PubMed ID: 6789299
[TBL] [Abstract][Full Text] [Related]
2. [Severe coagulopathy due to inhibitors of several clotting factors in IgM paraproteinaemia (author's transl)].
Hartmann S; Hartmann G; Duckert F
Dtsch Med Wochenschr; 1976 Feb; 101(8):286-91. PubMed ID: 1253737
[TBL] [Abstract][Full Text] [Related]
3. Acquired circulating anticoagulant with anti-factor V activity in AIDS: first case report.
Denis A; Baudeau C; Verdy E; Couderc R; Rondeau E; Sraer JD
Nouv Rev Fr Hematol (1978); 1995; 37(2):165-9. PubMed ID: 7644356
[TBL] [Abstract][Full Text] [Related]
4. Factor V inhibitor associated with immune complex formation.
Lazarchick J; Wolff CM; Pepkowitz SH; Kizer J; Romein LA
Arch Pathol Lab Med; 1986 May; 110(5):448-51. PubMed ID: 3754431
[TBL] [Abstract][Full Text] [Related]
5. [A case positive for the inhibitor for coagulation factor V].
Nakagoshi R; Takamiya O; Nakata S; Ishikawa S; Higuchi Y; Okumura N; Ogiso Y
Rinsho Byori; 1999 Oct; 47(10):971-5. PubMed ID: 10590673
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal IgG4 (lambda) with factor V inhibitory activity.
Hurtubise PE; Coots MC; Jacob DJ; Muhleman AF; Glueck HI
J Immunol; 1979 May; 122(5):2119-21. PubMed ID: 109525
[TBL] [Abstract][Full Text] [Related]
7. Acquired inhibitors of factor V.
Feinstein DI
Thromb Haemost; 1978 Jun; 39(3):663-74. PubMed ID: 705695
[TBL] [Abstract][Full Text] [Related]
8. Multimodality therapy of an acquired factor V inhibitor.
Fu YX; Kaufman R; Rudolph AE; Collum SE; Blinder MA
Am J Hematol; 1996 Apr; 51(4):315-8. PubMed ID: 8602633
[TBL] [Abstract][Full Text] [Related]
9. Inhibitor to factor V in severe factor V congenital deficiency. A case report.
Mazzucconi MG; Solinas S; Chistolini A; Motta M; Mariani G
Nouv Rev Fr Hematol (1978); 1985; 27(5):303-5. PubMed ID: 4080539
[TBL] [Abstract][Full Text] [Related]
10. Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors.
Berruyer M; Amiral J; Ffrench P; Belleville J; Bastien O; Clerc J; Kassir A; Estanove S; Dechavanne M
J Thorac Cardiovasc Surg; 1993 May; 105(5):892-7. PubMed ID: 8487567
[TBL] [Abstract][Full Text] [Related]
11. An acquired factor V inhibitor: clinical and laboratory features.
Shastri KA; Ho C; Logue G
J Med; 1999; 30(5-6):357-66. PubMed ID: 10851568
[TBL] [Abstract][Full Text] [Related]
12. [Acquired Willebrand factor deficiency associated with monoclonal IgG kappa gammapathy. Presence of an inhibitor of ristocetin co-factor (author's transl)].
Sitbon N; Horellou MH; Conard J; Perrot JY; Samama M; Fine JM; Gorin NC
Nouv Presse Med; 1981 Jun; 10(26):2171-4. PubMed ID: 6791124
[TBL] [Abstract][Full Text] [Related]
13. Factor V inhibitor in a liver transplant patient associated with porcine xenoperfusion.
Smith JD; Sindhi R; Rogers R; Lazarchick J
Ann Clin Lab Sci; 1998; 28(5):280-2. PubMed ID: 9784828
[TBL] [Abstract][Full Text] [Related]
14. [Clinical cases of acquired coagulation inhibitors].
Yamane T; Hino M; Ota K; Akahori M; Hirai M; Inoue T; Mugitani A; Tatsumi N
Rinsho Byori; 2000 Dec; 48(12):1093-101. PubMed ID: 11215417
[TBL] [Abstract][Full Text] [Related]
15. [Factor V inhibitor with double cancer].
Okajima A; Horii J; Nasu K; Niki Y; Akasaka K; Yamashita H; Sugimoto M; Yoshioka A
Rinsho Ketsueki; 1989 Apr; 30(4):514-9. PubMed ID: 2769972
[TBL] [Abstract][Full Text] [Related]
16. [Acquired factor V inhibitor treated with intravenous immunoglobulins].
Buclin T; Schmidt PM; Hauert J; Winkel L; Chapuis G; Bachmann F
Schweiz Med Wochenschr; 1992 Dec; 122(51-52):1968-70. PubMed ID: 1475662
[TBL] [Abstract][Full Text] [Related]
17. Deleted IgG1 and IgG2 H chains in a patient with an IgG subclass imbalance.
Lebreton JP; Fontaine M; Rousseaux J; Youinou P; Hurez D; Rivat-Peran L; Bernards JP
Clin Exp Immunol; 1982 Jan; 47(1):206-16. PubMed ID: 6807588
[TBL] [Abstract][Full Text] [Related]
18. [Acquired inhibitor against coagulation factor V with severe hematuria].
Hasegawa M; Tanaka T; Kii T; Fujiwara S; Ikeda N; Kinntaka D; Takeuti T; Tanaka H; Ikemoto T
Rinsho Ketsueki; 2003 Sep; 44(9):933-9. PubMed ID: 14577313
[TBL] [Abstract][Full Text] [Related]
19. [Hereditary factor V deficiency and factor V inhibitor without bleeding. Rare causes of pathological screening tests of coagulation].
Borucki K; Töpfer G; Hartung KJ; Lutze G
Hamostaseologie; 2007 Aug; 27(3):188-90. PubMed ID: 17694226
[TBL] [Abstract][Full Text] [Related]
20. High-titer acquired factor V inhibitor responsive to corticosteroids and cyclophosphamide in a patient with two malignant tumors.
Bayani N; Rugina M; Haddad-Vergnes L; Lelong F
Am J Hematol; 2002 Sep; 71(1):33-6. PubMed ID: 12221671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
